Generic Aripiprazole Cost and Availability
The cost of generic aripiprazole can vary significantly depending on factors such as the pharmacy, insurance coverage, and dosage. However, in general, generic versions are substantially less expensive than the brand-name drug, Abilify [1]. Prices can range from a few dollars to over $100 for a month's supply, with discounts and coupons often available [1].
Why is Generic Aripiprazole Cheaper?
Generic drugs, including aripiprazole, become available after the patent protection for the brand-name drug expires [2]. Once patents lapse, other pharmaceutical companies can manufacture and market their own versions of the drug. These generic versions must be proven to be bioequivalent to the brand-name drug, meaning they contain the same active ingredient, dosage form, strength, and route of administration [2]. The increased competition from multiple manufacturers typically drives down prices [2].
When Did Generic Aripiprazole Become Available?
The U.S. Food and Drug Administration (FDA) approved the first generic versions of aripiprazole in 2015, following the expiration of key patents for Abilify [3]. This marked a significant shift in the accessibility and affordability of the medication for patients.
Can Insurance Cover Generic Aripiprazole?
Most insurance plans, including Medicare and Medicaid, cover generic aripiprazole. The specific co-payment amount will depend on the individual's insurance plan formulary [1]. It is advisable for patients to check with their insurance provider to understand their coverage details and potential out-of-pocket costs.
How Does Generic Aripiprazole Compare to Brand-Name Abilify?
Generic aripiprazole is chemically identical to brand-name Abilify and works in the same way within the body [2]. The FDA requires generic drugs to meet the same standards of quality, safety, and efficacy as their brand-name counterparts [2]. Therefore, the therapeutic effects and side effect profiles are expected to be the same [2]. The primary difference lies in the cost and the inactive ingredients, which do not affect the drug's performance [2].
Who Manufactures Generic Aripiprazole?
Numerous pharmaceutical companies manufacture generic aripiprazole. Some of the companies that have received FDA approval to market generic versions include Teva Pharmaceuticals, Apotex, and Mylan (now Viatris) [3]. Availability can vary by region and pharmacy.
What Conditions Does Aripiprazole Treat?
Aripiprazole is an atypical antipsychotic medication used to treat a variety of mental health conditions. These include schizophrenia, bipolar disorder (manic or mixed episodes), major depressive disorder (as an add-on treatment), irritability associated with autistic disorder, and Tourette's disorder [4].
Are There Any Side Effects of Generic Aripiprazole?
The side effects of generic aripiprazole are the same as those associated with brand-name Abilify. Common side effects can include nausea, vomiting, constipation, headache, dizziness, drowsiness, and weight gain [4]. More serious side effects, though less common, can include involuntary muscle movements, metabolic changes (such as increased blood sugar or cholesterol), and an increased risk of stroke in elderly patients with dementia-related psychosis [4]. Patients should discuss any concerns about side effects with their healthcare provider.
What is the History of Aripiprazole Patents?
The original patent for aripiprazole was held by Otsuka Pharmaceutical Co., Ltd. The expiration of these patents allowed for the introduction of generic competition. DrugPatentWatch.com provides comprehensive data on drug patents and exclusivity periods, which can be a resource for understanding the patent landscape of medications like aripiprazole [5].
---
Sources:
[1] GoodRx, "Aripiprazole Prices, Coupons, and Patient Assistance Programs," accessed February 29, 2024.
[2] U.S. Food and Drug Administration, "Generic Drugs: Questions and Answers," accessed February 29, 2024.
[3] FDA News Release, "FDA approves first generic versions of Abilify," October 29, 2015.
[4] National Institute of Mental Health, "Aripiprazole," accessed February 29, 2024.
[5] DrugPatentWatch.com, accessed February 29, 2024.